Iron overload in MDS—pathophysiology, diagnosis, and complications Norbert GattermannEliezer A. Rachmilewitz Review Article 12 October 2010 Pages: 1 - 10
Deferasirox effectively decreases iron burden in patients with double heterozygous HbS/β-thalassemia Ersi VoskaridouEleni PlataEvangelos Terpos Original Article 27 July 2010 Pages: 11 - 15
Molecular characterization of a novel 27.6-kb deletion causing α+ thalassemia in a Chinese family Xiao-Feng WeiXuan ShangXiang-Min Xu Original Article 20 July 2010 Pages: 17 - 22
Sickle-cell disease and malaria: evaluation of seasonal intermittent preventive treatment with sulfadoxine-pyrimethamine in Senegalese patients—a randomized placebo-controlled trial Saliou DiopFabienne SoudréLamine Diakhaté Original Article 07 August 2010 Pages: 23 - 27
Prevalence of H63D, S65C, and C282Y hereditary hemochromatosis gene variants in Madeira Island (Portugal) Carla SpínolaAntónio BrehmHélder Spínola Original Article 17 August 2010 Pages: 29 - 32
Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) — a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia Michaela MuthBianca M. EngelhardtOliver Bock Original Article 13 July 2010 Pages: 33 - 40
Seven-year response to imatinib as initial treatment versus re-treatment in Chinese patients with chronic myelogenous leukemia in the chronic phase Hao JiangShan-Shan ChenXiao-Jun Huang Original Article 29 July 2010 Pages: 41 - 46
Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients YaZhen QinShanShan ChenXiaoJun Huang Original Article 10 August 2010 Pages: 47 - 52
Proteasome inhibitor bortezomib targeted tumor–endothelial cell interaction in T-cell leukemia/lymphoma Wen-Yu ShiLi WangWei-Li Zhao Original Article 09 July 2010 Pages: 53 - 58
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome Luca LaurentiLaura De PaduaGiuseppe Leone Original Article 13 July 2010 Pages: 59 - 65
Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin’s lymphoma Joanne NgeowIain B. TanSoon Thye Lim Original Article 31 July 2010 Pages: 67 - 72
Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: a methylation-specific polymerase chain reaction study using two different primer sets Geon ParkSeong Ho KangThe Korean Multiple Myeloma Working Party (KMMWP) Original Article 19 August 2010 Pages: 73 - 79
F-18 FDG uptake of bone marrow on PET/CT scan: it’s correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma İlknur AkZafer Gulbas Original Article 06 August 2010 Pages: 81 - 87
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim Panagiotis SamarasMarcel BlickenstorferChristoph Renner Original Article 13 August 2010 Pages: 89 - 94
Percutaneous vertebroplasty to treat painful myelomatous vertebral deposits—long-term efficacy outcomes Paula GarlandPhilip GishenAmin Rahemtulla Original Article 06 July 2010 Pages: 95 - 100
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature Sergio SiragusaWilliam MoriceAngela Dispenzieri Original Article 20 July 2010 Pages: 101 - 106
Intravascular large B-cell lymphoma originating in the left epididymis Xiaomei MaHuimin Liu Letter to the Editor 13 April 2010 Pages: 107 - 108
Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin’s lymphoma Philipp KieweEckhard Thiel Letter to the Editor 13 April 2010 Pages: 109 - 110
Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma Chun-Hung ChoWen-Lee HwangChieh-Lin Teng Letter to the Editor 21 April 2010 Pages: 111 - 112
Cytomegalovirus and Epstein–Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation Shu-Yi TsaoKung-Chao ChangTsai-Yun Chen Letter to the Editor 06 April 2010 Pages: 113 - 114
Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience Tommaso CaravitaAgostina SiniscalchiPaolo de Fabritiis Letter to the Editor 27 April 2010 Pages: 115 - 116
H1N1 in allogeneic stem cell recipients: courses of infection and influence of vaccination on graft-versus-host-disease (GVHD) Markus DitschkowskiAhmet H. ElmaagacliDietrich W. Beelen Letter to the Editor 30 April 2010 Pages: 117 - 118
Acquired haemophilia in a patient with discoid lupus Iris AppelmannChristoph BiermannRolf Mesters Letter to the Editor 14 May 2010 Pages: 119 - 120
Acute lymphoblastic leukemia masquerading as juvenile rheumatoid arthritis: response Ketan Prasad KulkarniRam Kumar Marwaha Letter to the Editor 05 May 2010 Pages: 121 - 122
Mild hemoglobin H-constant spring disease with β-thalassemia—a case report Dong-Zhi LiCan LiaoJian Li Letter to the Editor 10 April 2010 Pages: 123 - 124
A novel large deletion causing Hb Bart’s Hydrops Fetalis in South China Jingzhong LiuXingyuan JiaBai Xiao Letter to the Editor 12 May 2010 Pages: 125 - 126
